Search results
Michael Landon's Daughter Says He Didn't Make His Health 'a Priority' Before Death: 'He Put It...
People Magazine· 13 hours agoMichael Landon’s health was far from his No. 1 priority, according to his daughter. The actor, who...
Breaking down barriers: ROCK2 inhibition facilitates drug delivery in fibrotic pancreatic cancer
Medical Xpress· 4 days agoPancreatic cancer, recognized as one of the deadliest cancers, poses a persistent challenge for medical professionals globally due to ...
Can statins help prevent cancer? New study offers clues
MedicalNewsToday via AOL· 2 days agoA recent study found that using the statin pitavastatin may assist in blocking a particular...
23andMe reports positive phase 2 data for cancer drug By Investing.com
Investing.com· 7 days agoThe drug, an anti-CD200R1 antibody, is being tested as a monotherapy for neuroendocrine and ovarian ...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 6 days agoOn Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed...
A shot in the arm that can help fight cancer? How vaccine trials are showing promise.
USA TODAY via Yahoo News· 6 days agoSo, among other things, the New York City resident volunteered for a research trial, testing an ...
Tip Sheet: Breast cancer guidelines change again, | Newswise
Newswise· 5 days agoBelow are summaries of recent Fred Hutchinson Cancer Center research findings and other news. March is Colorectal Cancer Awareness Month, contact our media
Daily Briefing: Your condom in Congress
USA TODAY via Yahoo News· 5 days agoRead more A shot in the arm to fight cancer? Filko Prugo volunteered for a research trial, testing an experimental vaccine for people like him, who carry...
METIS Phase 3 Clinical Trial Met Primary Endpoint Significantly Delaying Time to Intracranial...
Morningstar· 7 days agoMETIS Phase 3 Clinical Trial Met Primary Endpoint Significantly Delaying Time to Intracranial Progression with Improved Quality of Life Deterioration-Free Survival The METIS trial demonstrated 21.9 months median time to intracranial progression for